NEXGEL, Inc. (NXGL) is a Medical instruments supplies company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for NEXGEL, Inc. in 2026. The next earnings report is expected on November 17, 2026.
Next earnings date
17 Nov 2026
In 88 days
EPS estimate
-0.04
Revenue estimate
6.9M
Past earnings
Latest earnings analysis
NEXGEL, Inc. met consensus estimates in its latest earnings report, with EPS of -$0.12 matching expectations and revenue of $4.32 million in line with estimates, a 0.0% surprise. In the previous report, both EPS and revenue missed expectations.
No dividend history available.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
NEXGEL, Inc. (NXGL) is scheduled to report earnings on November 17, 2026.
NEXGEL, Inc. (NXGL) last reported earnings on August 17, 2026.
NEXGEL, Inc. (NXGL) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.